Cold-chain dispatchMOTS-c 20 mg
MOTS-c is a mitochondrial-derived peptide — encoded in the mitochondrial genome rather than the nuclear genome, which makes it unusual.
20 mg cartridge. Fits the reusable pen. Subcutaneous, once weekly.
MOTS-c is unusual before its mechanism is even considered: it is encoded in the mitochondrial genome rather than the nuclear one, making it a mitochondrial-derived peptide. It was only identified in 2015.
Its principal studied mechanism is activation of the AMPK pathway — the same cellular energy sensor that exercise and caloric restriction switch on. That is the basis for the shorthand that it echoes exercise in signal, though it plainly isn't a substitute for training.
Research covers insulin sensitivity, metabolic flexibility and exercise performance, which is why it pairs naturally with the GLP-1 range: appetite handled on one side, glucose handling on the other.
Methylene blue turns up in every longevity feed. Here is the actual chemistry, what published research describes about mitochondrial function, and how it is supplied locally.
ReadRecoveryTwo of the most-discussed research peptides in the recovery space — what the published literature describes, how they are usually studied together, and where the honest limits are.
Read
